Additionally, increased CD24 promoted the activation of ERK1/2, Raf-1, and p38 MAPK, confirming that CD24-dependent ERK1/2 and p38 MAPK activation were necessary for CRC proliferation. The gene discussed is CD24; the disease is colorectal carcinoma.